CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 153 filers reported holding AIMMUNE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.71 and the average weighting 0.4%.

Quarter-by-quarter ownership
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$2,421,000
+106.7%
70,264
+0.2%
0.00%
+100.0%
Q2 2020$1,171,000
+19.5%
70,107
+3.1%
0.00%0.0%
Q1 2020$980,000
-57.4%
67,968
-1.1%
0.00%
-50.0%
Q4 2019$2,301,000
+58.7%
68,736
-0.7%
0.00%
+33.3%
Q3 2019$1,450,000
+1.8%
69,230
+1.2%
0.00%0.0%
Q2 2019$1,424,000
-5.6%
68,403
+1.3%
0.00%0.0%
Q1 2019$1,509,000
-7.9%
67,517
-1.5%
0.00%
-25.0%
Q4 2018$1,639,000
-9.3%
68,517
+3.4%
0.00%0.0%
Q3 2018$1,807,000
+1.4%
66,248
-0.0%
0.00%0.0%
Q2 2018$1,782,000
+3.4%
66,272
+22.4%
0.00%0.0%
Q1 2018$1,723,000
-17.9%
54,145
-2.4%
0.00%0.0%
Q4 2017$2,098,000
+49.5%
55,470
-2.0%
0.00%
+33.3%
Q3 2017$1,403,000
+9.5%
56,597
-9.2%
0.00%0.0%
Q2 2017$1,281,000
+13.8%
62,315
+20.3%
0.00%
+50.0%
Q1 2017$1,126,000
+1.5%
51,815
-4.4%
0.00%0.0%
Q4 2016$1,109,000
+33.1%
54,215
-2.3%
0.00%0.0%
Q3 2016$833,000
+39.8%
55,515
+0.7%
0.00%
+100.0%
Q2 2016$596,000
+86.8%
55,115
+133.9%
0.00%0.0%
Q1 2016$319,000
-16.1%
23,560
+14.4%
0.00%0.0%
Q4 2015$380,000
-26.1%
20,593
+1.4%
0.00%0.0%
Q3 2015$514,00020,3000.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Aisling Capital LLC 1,240,000$25,966,00057.34%
Foresite Capital Management II, LLC 2,605,499$54,559,00011.53%
Foresite Capital Management III, LLC 611,893$12,813,0004.89%
Palo Alto Investors LP 3,471,740$72,698,0004.84%
SANDERS MORRIS HARRIS LLC 486,906$10,196,0002.47%
Eventide Asset Management 3,084,000$64,579,0002.13%
Sofinnova Investments, Inc. 346,770$7,261,0000.66%
EMERALD ADVISERS, LLC 610,511$12,784,0000.60%
RICE HALL JAMES & ASSOCIATES, LLC 752,358$15,754,0000.56%
EMERALD MUTUAL FUND ADVISERS TRUST 587,464$12,301,0000.54%
View complete list of AIMMUNE THERAPEUTICS INC shareholders